Aeveron Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 5 Months
About Aeveron Pharmaceuticals
Aeveron Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 31 August 2021 (Three years and five months 9 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Kamini Desai and Harsha Shetty serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100MH2021PTC366658
-
Company No.
366658
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
31 Aug 2021
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Aeveron Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kamini Desai
|
Director | 31-Aug-2021 | Current |
|
Harsha Shetty
|
Director | 31-Aug-2021 | Current |
Financial Performance of Aeveron Pharmaceuticals.
Enhance accessibility to Aeveron Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aeveron Pharmaceuticals?
Unlock access to Aeveron Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Aeveron Lifesciences LlpKamini Desai and Harsha Shetty are mutual person
-
Fashionfella Private Limited
Kamini Desai and Harsha Shetty are mutual person
-
Dpj International Clothing Private Limited
Kamini Desai and Harsha Shetty are mutual person
-
Axis Clothing & Design Company Private Limited
Kamini Desai is a mutual person
-
Proclust Innovative Services Private Limited
Kamini Desai and Harsha Shetty are mutual person
-
Rup And Easy Private Limited
Kamini Desai and Harsha Shetty are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aeveron Pharmaceuticals?
Aeveron Pharmaceuticals has a workforce of 0 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aeveron Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aeveron Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.